WAYNE, Pa.--(BUSINESS WIRE)--Oct. 27, 2014--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, has announced that the ARROW®
EZ-IO® Vascular Access System has reached a new growth milestone by
surpassing 3 million needles sold globally in early September 2014.
“This is a significant milestone for the Arrow® EZ-IO® Vascular Access
System because it demonstrates that IO is gaining acceptance for
emergency and difficult vascular access,” said Jay White, President and
General Manager, Vascular Access Division, Teleflex. “It demonstrates
the lifesaving capabilities of the EZ-IO vascular Access System through
its clinical benefits centered around ease of use, speed to vascular
access, and safety.”
The Arrow® EZ-IO® Vascular Access System is a safe, fast, effective
vascular access option that provides peripheral venous access with
central venous catheter performance. It’s ideal for patients in whom
peripheral vascular access is difficult or impossible in the hospital
and pre-hospital setting.
In a recent Huffington
Post article profiling Dr. Suzanne Donovan, a physician traveling to
Sierra Leone to fight the recent Ebola outbreak, intraosseous (IO)
infusion was identified as one of the safest ways of providing fluids to
patients who can't take oral fluids. Teleflex is proud to have supported
Dr. Donovan’s efforts with a donation.
Teleflex will feature the ARROW® EZ-IO® Vascular Access System at the
upcoming annual conferences for the American College of Emergency
Physicians (ACEP) and EMS World Expo. Both conferences will feature
educational cadaver labs that will provide a unique hands-on opportunity
for participants to practice vascular access techniques as well as
receive an in-depth review of associated anatomy on cadaveric specimens.
ACEP 2014 will be held October 27-30 at the McCormick Convention Center,
in Chicago, IL. EMS World Expo will be held November 9-13 at the Music
City Center, in Nashville, TN.
Potential complications with the ARROW® EZ-IO® Vascular Access System
may include local or systemic infection, hematoma, extravasations, or
any other complications associated with percutaneous insertion of
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Wayne, PA,
Teleflex employs approximately 11,500 people worldwide and serves
healthcare providers in more than 150 countries. Additional information
about Teleflex can be obtained from the company's website at teleflex.com.
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements.
These risks and uncertainties are identified and described in more
detail in our filings with the Securities and Exchange Commission,
including our Annual Report on Form 10-K.
Teleflex, Arrow, and EZ-IO are trademarks of Teleflex Incorporated and
© 2014 Teleflex Incorporated. All rights reserved. MC-000738
Source: Teleflex Incorporated
Treasurer and Vice
President, Investor Relations